EQIPD members report on ongoing activities

In its summer newsletter, the European Quality in Preclinical Data (EQIPD) project reported that members are completing the development of a novel research quality system that is intended to support the discovery and development of innovative therapies and that can be applied in both industry and academia. While the system is still in beta-testing phase, the consortium has released a white paper describing the key elements of the system and the concept behind.

The EQIPD will be featured at the 33rd ECNP Congress (virtual, 12-15th September 2020). The ECNP Congress annually attracts between 5,000 and 6,000 psychiatrists, neuroscientists, neurologists, psychologists and neurobiologists from 100 countries around the world, making it the largest meeting for applied and translational neuroscience in Europe.

  • The EQIPD project is presenting at the exhibition of the 33rd ECNP Congress. Visit the virtual stand to get to know more about the project and contact the partners involved in the project.
  • The project will also host the Campfire Session ‘Don’t get lost in clinical translation: improved quality in preclinical data’ on Monday 14 September, 13.00-13.30. The session will start with consortium partner Lucas Noldus introducing the EQIPD project and presenting recent developments with respect to research guidelines, the quality management system, and the education platform. In this campfire session, unmet needs with respect to quality management tools and behavioural testing tools will be discussed with the congress participants.

In addition, EQIPD welcomes IMI-Pain Care to its team and looks forward to the outputs of this collaboration. The IMI-PainCare consortium have reached out to EQIPD to collaborate in assessing the design and data analysis of their studies within the subgroups BioPain and TRiPP. This collaboration will ensure equivalent quality standards in preclinical research among their project members, thereby allowing for successful reproducibility, reducing failure rates, and lowering the time and costs associated. EQIPD welcomes IMI-Pain Care to the team and looks forward to the outputs of this collaboration.

Read the newsletter here.